SCHEMBL21912169

SCHEMBL21912169

C=CC[C@@H](CCCC)COc1nc2c(c(N(CCC(C=C)C(=O)C=C)CC(C)CC#N)n1)CCC(C=C)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21896256 0.90 — —
SCHEMBL21912768 0.82 — —
SCHEMBL21895589 0.82 — —
SCHEMBL22086726 0.78 — —
SCHEMBL21912060 0.77 — —
SCHEMBL21912184 0.76 — —
SCHEMBL19637187 0.76 — —
SCHEMBL22087290 0.71 KRAS (0.36) —
SCHEMBL21912130 0.71 KRAS (0.36) —
SCHEMBL22087711 0.69 KRAS (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020055755-A1 COMBINATION THERAPIES Mirati Therapeutics, Inc. (US) 2020-03-19 — — WO disclosed
Send feedback